The Healthy @Reader's Digest on MSN

In a New Study, Dogs Detected the Second-Most-Common Neurological Disease—After Alzheimer’s—20 Years Ahead of Doctors

It's a condition that's currently without an early diagnostic test, but there's a surprising—and furry—hint of hope for the ...
Healio

Roflumilast foam efficacious, well-tolerated in seborrheic dermatitis

MILAN — In patients with seborrheic dermatitis, once-daily roflumilast foam had a significant impact on skin clearance and itch response and was tolerated well, according to phase 3 trial results.
Nasdaq

ZORYVE® (roflumilast) Topical Foam, 0.3%, for the Treatment of Seborrheic Dermatitis Launches in the United States

WESTLAKE VILLAGE, Calif., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in ...
La Grande Observer

Odell Beckham Jr. and Arcutis Tackle Seborrheic Dermatitis in a “Clear Win for Your Skin”

Odell Beckham Jr. first noticed flakes throughout his iconic beard and hairline in his 20s; today, for the first time he is sharing his experience with ZORYVE® (roflumilast) topical foam, 0.3%, to ...